- Trials with a EudraCT protocol (25)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (16)
25 result(s) found for: Metoclopramide.
Displaying page 1 of 2.
EudraCT Number: 2014-004282-25 | Sponsor Protocol Number: CHUBX2014/10 | Start Date*: 2015-03-25 |
Sponsor Name:CHU de Bordeaux | ||
Full Title: Subcutaneous route and pharmacology of metoclopramide - SOPHA-Méto | ||
Medical condition: Digestive disorder (Nausea and vomiting) in palliative care and oncology | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-003137-42 | Sponsor Protocol Number: EPIFLUX | Start Date*: 2020-04-10 |
Sponsor Name:Medizinische Universität Wien, Universitätsklinik für Klinische Pharmakologie | ||
Full Title: Exploring P-glycoprotein-mediated efflux transport at the blood-brain barrier as a biomarker of drug-resistance in focal epilepsy | ||
Medical condition: Investigation in healthy volunteers and epilepsy patients | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000723-94 | Sponsor Protocol Number: LP101-CL-201 | Start Date*: 2016-08-17 | |||||||||||
Sponsor Name:Lyric Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, Multicenter, Randomized, Double-Blind, Comparator-Controlled Study of the Efficacy, Safety, and Pharmacokinetics of Intravenous Ulimorelin (LP101) in Patients with Enteral Feeding Intole... | |||||||||||||
Medical condition: Enteral Feeding Intolerance | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-001651-31 | Sponsor Protocol Number: 1.0 | Start Date*: 2017-11-30 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: EMPOWER: EMesis in Pregnancy - Ondansetron With mEtoclopRamide. | ||
Medical condition: Nausea and Vomiting in pregnancy Hyperemesis gravidarum | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-001374-29 | Sponsor Protocol Number: 1 | Start Date*: 2012-11-30 | |||||||||||
Sponsor Name:North Bristol NHS Trust | |||||||||||||
Full Title: Delivering adequate nutrition to critically ill patients suffering delayed gastric emptying: RCT of nasointestinal feeding versus nasogastric feeding plus prokinetics. | |||||||||||||
Medical condition: Delayed gastric emptying, refractory to 24h of metoclopramide treatment in mechanically ventilated patients. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004446-17 | Sponsor Protocol Number: MEDEA001 | Start Date*: 2012-03-13 | |||||||||||
Sponsor Name:VU University Medical Center Amsterdam | |||||||||||||
Full Title: Metoclopramide, dexamethasone or Aloxi for the prevention of delayed chemotherapy-induced nausea and vomiting in moderately emetogenic non-AC-based chemotherapy: the MEDEA trial | |||||||||||||
Medical condition: Patients with cancer receiving moderately emetogenic non-AC-based chemotherapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-004423-19 | Sponsor Protocol Number: CF/01 | Start Date*: 2005-12-06 |
Sponsor Name:The North West London Hospitals NHS Trust, Northwick Park Hospital | ||
Full Title: A randomised study of the optimal bowel preparation for routine Capsule endoscopy using Citramag and Senna or Metoclopramide. | ||
Medical condition: Investigation of suspected small bowel disease by Capsule Endoscopy | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2008-002086-31 | Sponsor Protocol Number: RC 32\07 | Start Date*: 2008-01-14 | |||||||||||
Sponsor Name:ISTITUTO PER L'INFANZIA BURLO GAROFOLO | |||||||||||||
Full Title: Randomized controlled Trial on the effectiveness of metoclopramide alone or in combination with ketoprofene, versus ketoprofene in acute migraine of child | |||||||||||||
Medical condition: Acute Migraine in childhood | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003406-14 | Sponsor Protocol Number: UHNM1219 | Start Date*: 2017-09-26 | |||||||||||||||||||||
Sponsor Name:University Hospital of North Midlands NHS Trust | |||||||||||||||||||||||
Full Title: The Metoclopramoide and selective oral decontamination for Avoiding Pneumonia after Stroke (MAPS-2) Trial: a 2x2 double-blind, randomized controlled trial of metoclopramide and selective oral decon... | |||||||||||||||||||||||
Medical condition: Stroke We are testing two differnt intervetnions which could prevent pneumonia in stroke patietns. Prevention pneumonia could potentiallly speed up recovery and improve survival. | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-003367-40 | Sponsor Protocol Number: 2007/049/HP | Start Date*: 2009-03-03 |
Sponsor Name:CHU de Rouen | ||
Full Title: Pilot study of the effect of a substance P antagonist, aprepitant, on aldosterone and cortisol secretions in healthy volunteers | ||
Medical condition: The aim is to measure plasma aldosterone and cortisol concentrations in basal conditions and in response to different stimulation tests of the adrenal function | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: FR (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000503-16 | Sponsor Protocol Number: P170903J | Start Date*: 2021-02-12 |
Sponsor Name:Assistance Publique- Hôpiaux de Paris | ||
Full Title: Randomized, double-blind, single-centre, randomized study evaluating the efficacy of CLORazepate dipotassium in the treatment of migraine crisis in the emergency department. | ||
Medical condition: Adults of full age, excluding pregnant or breastfeeding women, admitted to the CUC for headaches | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-003179-32 | Sponsor Protocol Number: ToL54304 | Start Date*: 2016-02-03 | |||||||||||||||||||||
Sponsor Name:University Medical Center Utrecht | |||||||||||||||||||||||
Full Title: PREvention of Complications to Improve Outcome in elderly patients with acute Stroke. A randomised, open, phase III, clinical trial with blinded outcome assessment. | |||||||||||||||||||||||
Medical condition: Stroke (ischaemic stroke or intracerebral hemorrhage) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: NL (Completed) HU (Completed) GR (Completed) IT (Ongoing) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-011122-33 | Sponsor Protocol Number: EC08/00281 | Start Date*: 2009-07-09 |
Sponsor Name:FUNDACION PARA LA INVESTIGACION BIOMEDICA HOSPITAL 12 DE OCTUBRE | ||
Full Title: LA ANALGESIA DEL PARACETAMOL,¿DISMINUYE CUANDO SE ADMINISTRAN ANTIEMÉTICOS ANTISEROTONINÉRGICOS | ||
Medical condition: ANALGESIA POSTOPERATORIA AGUDA EN PROTESIS TOTAL DE RODILLA | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-004720-37 | Sponsor Protocol Number: Voluven_v1.0fr | Start Date*: 2006-12-11 | |||||||||||
Sponsor Name:CUB Hôpital Erasme, Department of Anesthesiology | |||||||||||||
Full Title: Effect of Voluven on postoperative morbidity after gynaecological surgery | |||||||||||||
Medical condition: Healthy female patients (American Society of Anaesthesiologists score I or II) programmed for elective gynaecological surgery and at least 18 years old | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003206-41 | Sponsor Protocol Number: TAK-954-2002 | Start Date*: 2018-05-29 | |||||||||||
Sponsor Name:Millennium Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2b, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous TAK-954 in Critically Ill Patients With Enteral Feeding Int... | |||||||||||||
Medical condition: A Phase 2b, Randomized, Multi-Center, Double-Blind, Dose-Ranging Study to Assess the Efficacy, Safety and Pharmacokinetics of Intravenous TAK-954 in Critically Ill Patients With Enteral Feeding Int... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2010-018665-30 | Sponsor Protocol Number: KKSH-079 | Start Date*: 2010-06-30 | ||||||||||||||||
Sponsor Name:Martin-Luther University Halle-Wittenberg | ||||||||||||||||||
Full Title: COMFORT-study Comparison of Olanzapin and Metoclopramide For treatment Of bReakThrough emesis | ||||||||||||||||||
Medical condition: Patienten, die trotz maximaler Standardantiemese mit Granisetron, Dexamethason und Aprepitant unter chemotherapie-induzierter Übelkeit und Erbrechen leiden. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-003669-32 | Sponsor Protocol Number: GONO-Sancuso | Start Date*: 2020-07-03 | |||||||||||
Sponsor Name:G.O.N.O. - GRUPPO ONCOLOGICO DEL NORD OVEST | |||||||||||||
Full Title: GRANISETRON TRANSDERMAL SYSTEM (GTDS) IN PREVENTING NAUSEA AND VOMITING INDUCED BY CISPLATIN-BASED CHEMOTHERAPY AND CONCURRENT RADIOTHERAPY FOR HEAD AND NECK CANCER | |||||||||||||
Medical condition: Head and neck cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001339-37 | Sponsor Protocol Number: 2008-001339-37 | Start Date*: 2008-04-10 | ||||||||||||||||
Sponsor Name:AZIENDA OSPEDALIERA S. MARIA DI TERNI | ||||||||||||||||||
Full Title: Aprepitant in the prevention of cisplatin-induced delayed emesis: a double-blind randomized study | ||||||||||||||||||
Medical condition: patiens with different cancers submitted to single dose of cisplatin chemotherapy | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004687-37 | Sponsor Protocol Number: 14SM2335 | Start Date*: 2016-06-17 | |||||||||||
Sponsor Name:Imperial College Healthcare NHS Trust | |||||||||||||
Full Title: Use of Methylnaltrexone for the Treatment of Opioid Induced Constipation & Gastro-Intestinal Stasis in Intensive Care Patients | |||||||||||||
Medical condition: Opioid Induced Constipation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-000271-39 | Sponsor Protocol Number: 2022-01 | Start Date*: 2022-09-02 | |||||||||||
Sponsor Name:Adeptio Pharmaceuticals Ltd | |||||||||||||
Full Title: Single-arm, open-label dose titration phase 2 clinical trial of (+)-α-DHTBZ for the treatment of tardive dyskinesia (TD) | |||||||||||||
Medical condition: Tardive dyskinesia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HR (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.